Healthcare >> CEO Interviews >> October 17, 2003
ARNOLD S. LIPPA is a co-Founder, President and Chief Executive Officer
of DOV Pharmaceutical, Inc. Dr. Lippa also serves as Secretary and is a
Director and co-Chairman of its Board of Directors. Dr. Lippa also
serves as Director and Chairman of Nascime Limited, a company formed in
connection with the Elan joint venture. Prior to founding DOV in 1995,
Dr. Lippa founded Fusion Associates, Ltd., an investment and management
company specializing in the creation and management of biomedical
companies. Dr. Lippa served as Fusion's Managing Director from 1991 to
1995. From 1989 through 1990, Dr. Lippa served as Vega Biotechnologies,
Inc.'s Chairman and Chief Executive Officer. In 1984, Dr. Lippa co-
founded Praxis Pharmaceuticals, Inc., and served as President and Chief
Operating Officer until 1988. In addition, Dr. Lippa has consulted for
various pharmaceutical and biotechnology companies and has been a
graduate faculty professor at the New York University School of Medicine
and the City University of New York. He received his BA from Rutgers
University in 1969 and his PhD in Psychobiology from the University of
Pittsburgh in 1973. Profile
Dr. Lippa: DOV is focused on the development of drug candidates
primarily for central nervous system disorders. We
